| Name | Title | Contact Details |
|---|---|---|
Eric Feibelman |
Chief Information Officer | Profile |
David Cohen |
Chief Product and Technology Officer | Profile |
Kali Durgampudi |
Chief Technology and Innovation Officer | Profile |
Larry Whiteside |
Chief Information Security Officer | Profile |
Don Kleoppel |
Chief Information and Security Officer | Profile |
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.
HealthReveal is a clinical AI company dedicated to improving outcomes and quality of life for patients with chronic disease by enabling clinicians to deliver the most effective evidence-based treatments tailored to each patient’s unique circumstances, every time. By using machine learning and bridging each patient’s information with the latest medical guidelines, we predict individual patient health risks and disease progression and prescribe individual treatment interventions to mitigate risks, improve quality and reduce costs.
Vivascience is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sherman Health Systems is a Elgin, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedImmune strives to provide better medicines to patients, new medical options for physicians, and rewarding careers to employees.